NetworkNewsBreaks – Predictive Oncology Inc. (NA
Post# of 281
Predictive Oncology (NASDAQ: POAI) on Monday announced that it repaid or extended the secured promissory notes that were due September 28, 2019. POAI repaid the remaining principal and interest balance of $478,590 on one note on September 27th. The company also secured a new investment of $700,000 from a private investor in exchange for a new 8% secured promissory note due on March 27, 2020 with an original principal amount of $847,500. POAI issued 88,574 shares of common stock and a 682,368 share warrant to the new investor. The company also amended the other outstanding note to extend the maturity date from September 28, 2019 to December 31, 2019. The outstanding principal amount of the note was increased by $120,000 to $1,789,104, and the company issued 150,000 shares of common stock to the investor per the amended terms.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer